| 序号 | 专利名 | 申请号 | 申请日 | 公开（公告）号 | 公开（公告）日 | 发明人 |
|---|---|---|---|---|---|---|
| 81 | 복소환식 화합물 | KR1019840006968 | 1984-11-07 | KR1019850003889A | 1985-06-29 | 윌리암죤코우츠 |
| 내용없음 | ||||||
| 82 | 1,2,3- 티아디아졸-5-일-우레아 유도체의 제조 방법 | KR1019820004448 | 1982-09-30 | KR1019840001562A | 1984-05-07 | 프리드리히아른트-2 |
| 내용없음 | ||||||
| 83 | N-치환 아닐린 유도체의 제조 공정 | KR1019810002933 | 1981-08-12 | KR1019830006254A | 1983-09-20 | 게머하드햄프렉트외3 |
| 내용없음 | ||||||
| 84 | 할로겐화 알킬로부터 유기 티오시안산 화합물의 제조방법 | KR1020110060186 | 2011-06-21 | KR1020120140445A | 2012-12-31 | 경영수 |
| PURPOSE: A manufacturing method of organic thiocyanate from halogenated alkyl by using a layer separation is provided to easily isolate and purify tetrazole -5- thione compound by using a layer separation. CONSTITUTION: A manufacturing method of organic thiocyanate from halogenated alkyl by using a layer separation comprises the following steps: manufacturing a mixture of organic thiocyanate and isothiocyanate compound by reacting the organic halogen compound with thiocyanate ion; manufacturing tetrazole-5-thione by reacting the mixture with azide ion under basic condition; and layer separating and removing the tetrazole -5- thione. | ||||||
| 85 | 할로겐화 알킬로부터 유기 티오시안산 화합물의 합성방법 | KR1020110060185 | 2011-06-21 | KR1020120140444A | 2012-12-31 | 경영수 |
| PURPOSE: A synthesis method of organic thiocyanate compound from halogenated alkyl capable of isolate purifying the thiocyanate compound is provided to easily isolate and purify the thiocyanic acid compound and thiatriazole amine by using polarity difference of substances. CONSTITUTION: A synthesis method of organic thiocyanate compound from halogenated alkyl comprises the following steps: manufacturing a mixture of organic thiocyanate compound and isothiocyanate compound by reacting thiocyanate ion with the organic halogen compound; manufacturing thiatriazole amine by reacting the mixture with azide ion under acidic condition; and removing the thiatriazole amine by using a column chromatography method. | ||||||
| 86 | 환형 퍼플루오로알칸비스(설포닐)이미드의 제조 방법 및 그 신규한 4원 이미드 | KR1019980706846 | 1997-02-20 | KR1019990087426A | 1999-12-27 | 폴루드비히; 힐라리우스폴커; 사르토리페터; 유쉬케랄프 |
| 본 발명은 환형 퍼플루오로알칸비스(설포닐)이미드 및 그의 염의 제조 방법에 관한 것이다. 신규한 화합물인 리튬 사이클로디플루오로메탄비스(설포닐)이미드는 리튬 이차 전지용 비수계 전해질에서 전도성 염으로서 특히 적당하다. | ||||||
| 87 | 트리 메틸렌 옥시 그룹을 함유하는 액정 성분 | KR1019890007391 | 1989-05-31 | KR1019900017974A | 1990-12-20 | 스테펜켈리 |
| 내용 없음 | ||||||
| 88 | 티아 트리아진 유도체의 제조 방법 | KR1019830004491 | 1983-09-26 | KR1019840006226A | 1984-11-22 | 배리클라아브로스; 제프리다니엘미쎌; 시몬죤코우신스 |
| 내용없음 | ||||||
| 89 | 5- 페녹시 페닐- 테트라 히드로- 1,3,5- 티아디아진-4-온의 제조 방법 | KR1019820003982 | 1982-09-03 | KR1019840001563A | 1984-05-07 | 살렘파루크-1 |
| 내용없음 | ||||||
| 90 | 유기 전계 발광 소자 및 유기 전계 발광 소자용 다환 화합물 | KR1020180155173 | 2018-12-05 | KR102623053B1 | 2024-01-10 | |
| 91 | 유기 전계 발광 소자 및 유기 전계 발광 소자용 다환 화합물 | KR1020180155173 | 2018-12-05 | KR1020200068791A | 2020-06-16 | |
| 92 | 정제된 함불소 비스술포닐이미드의 암모늄염의 제조 방법 | KR1020107001596 | 2008-08-15 | KR1020100042264A | 2010-04-23 | 이와야마사오 |
| Disclosed are a method for producing an ammonium salt a fluorinated bis-sulfonylimide and a method for producing a lithium salt of a fluorinated bis-sulfonylimide, each by employing a practical and efficient method having a high collection rate and comprising a fewer steps. Also disclosed is a highly pure ammonium salt of a fluorinated bis-sulfonylimide, which is useful in the method for producing the lithium salt. Specifically disclosed is a method for producing a purified particle-like solid (II) of a salt represented by the formula (1), which comprises the steps of: suspending a particle-like solid (I) of the salt represented by the formula (1) in a solvent comprising an ether-type compound containing an oxygen atom; and separating the solvent by filtration. [HNR][Q-SO-N-SO-Q](1) wherein R's independently represent a hydrogen atom or an alkyl group having 1 to 10 carbon atoms; and Qand Qindependently represent a univalent fluorinated organic group, or Qand Qtogether form a bivalent fluorinated organic group. | ||||||
| 93 | 칼시토닌 유전자 관련 펩티드 수용체 길항제 | KR1020067013470 | 2003-12-05 | KR1020060125832A | 2006-12-06 | 데그난,앤드류,피.; 첸,링; 시비엘로,리타; 두보우칙,진,엠.; 한,시아오준; 지앙,시앙,준,제이.; 마코르,존,이.; 토라,조지; 루오,광린 |
| The present invention relates to compounds of Formula (I) as antagonists of calcitonin gene-related peptide receptors ("CGRP-receptor"), pharmaceutical compositions comprising them, methods for identifying them, methods of treatment using them and their use in therapy for treatment of neurogenic vasodilation, neurogenic inflammation, migraine and other headaches, thermal injury, circulatory shock, flushing associated with menopause, airway inflammatory diseases, such as asthma and chronic obstructive pulmonary disease (COPD), and other conditions the treatment of which can be effected by the antagonism of CGRP-receptors. | ||||||
| 94 | 2-(N-치환된 구아니디노)-4-헤테로아릴티아졸의 제조방법 | KR1019850002872 | 1985-04-29 | KR100023968B1 | 1987-08-06 | 로렌스알렌라이터 |
| 95 | 2-(N-치환된 구아니디노)-4-헤테로아릴티아졸의 제조방법 | KR1019850002872 | 1985-04-29 | KR1019870000925B1 | 1987-05-07 | 로렌스알렌라이터 |
| The title compds. (I) or its pharmaceutically innoxious acid addn. salts are prepd. by reacting R1R2NC(=NH)NHC=SNH2 with equal molar amts. of (II) in the presence of inert organic solvent i.e. acetone or dimethylformamide at 20-120≦̸C. Y=CH; X=S or NH; R1= straight or side-chain C4-10 alkyl, phenyl or R3Ar(CH2)n[n=1-4 integer; R3=H, F, Cl, CH3O; Ar=phenyl, naphthyl, pyridyl ; R2=H; R4=H, C1-5 alkyl or NH2; hal=Cl or Br. (I) are useful for treatment of ulcer. | ||||||
| 96 | 2-(N-치환된 구아니디노)-4-헤테로아릴티아졸의 제조방법 | KR1019850002872 | 1985-04-29 | KR1019850007263A | 1985-12-02 | 로렌스알렌라이터 |
| 내용 없음 | ||||||
| 97 | 1,2,3- 티아디아졸-5-일-우레아 유도체의 제조 방법 | KR1019820004447 | 1982-09-30 | KR1019840001561A | 1984-05-07 | 프리드리히아른트-2 |
| 내용없음 | ||||||
| 98 | 2-아미노-5-(0-술포 아미노 페닐)-1,3,4- 티아 디아졸 유도체의 제조 방법 | KR1019820001131 | 1982-03-17 | KR1019830009068A | 1983-12-17 | 기오바니오르잘레시 |
| 내용없음 | ||||||
| 99 | 由金屬離子導引所形成之準車輪烷、車輪烷與交環烷的結構 | TW102118529 | 2013-05-24 | TW201444811A | 2014-12-01 | 邱勝賢; CHIU, SHENGHSIEN; 林祐涵; LIN, YOUHAN |
| 在此揭露由金屬離子導引所形成之準車輪烷、車輪烷與交環烷的結構。準車輪烷至少包括一巨環主體分子、一客體分子以及一金屬離子。主體分子包括至少一結合單元與一芳香環連接單元。客體分子具有至少一辨識單元。利用金屬離子傾向鍵結配位至由主體分子的結合單元與客體分子的辨識單元所組成之結合口袋的特性，可導引客體分子穿透巨環主體分子而形成準車輪烷的結構。而具有或不具有金屬離子的車輪烷或交環烷則可由準車輪烷來製備之。 | ||||||
| 100 | Modulators of Alpha-4-beta-7 Integrin and MAdCAM | US17938236 | 2022-10-05 | US20230145835A1 | 2023-05-11 | John J. DWYER; Jessica CAO |
| The instant disclosure describes novel modulators of alpha α4β7 and/or MAdCAM and their use for the treatment of diseases and conditions associated with their biological function. Further described herein are methods of treating diseases or conditions associated with α4β7 and/or MAdCAM. | ||||||
QQ群二维码
意见反馈
意见反馈